Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Obesity affects skin health, causing conditions like acanthosis nigricans and may require different treatment approaches.

Insulin resistance is a key factor in polycystic ovary syndrome, but genetics may also contribute.

Insulin resistance and obesity are key factors in the development and worsening of polycystic ovary syndrome, and lifestyle changes are important for managing it.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Improving insulin sensitivity and weight loss can help manage polycystic ovary syndrome (PCOS).

PCOS symptoms change with age; younger women have higher androgen levels and less metabolic issues, while older women face more metabolic challenges despite milder PCOS symptoms.

PCOS is often linked to insulin resistance and obesity, and weight loss can improve symptoms.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

PNU 157706 is a more effective treatment than finasteride for conditions caused by DHT, like enlarged prostate and hair loss.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

Researchers developed a method to grow hair follicle cells for transplantation using a special chip.

New treatments for ichthyosis, like protein replacement and gene therapy, show promise and may become standard care.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

Higher fiber intake may reduce psoriasis severity, but more research is needed for effective dietary strategies.

Metformin helps manage diabetes, PCOS, and weight in kids but needs more research for long-term safety.

The document suggests various treatments for PCOS, including medication for menstrual issues, insulin resistance, and excess hair, as well as fertility treatments, while highlighting the need for personalized care and lifestyle changes.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

Researchers found WNT10A to be a key gene in developing goat hair follicles.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Bolandiol, a synthetic steroid, builds muscle and bone without greatly affecting sex glands, and works differently from other hormones.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

In 2024, the FDA approved 27 innovative small-molecule drugs, with many offering significant treatment improvements.

Women with non-classical congenital adrenal hyperplasia have higher levels of certain steroids, which can be reduced by treatment.

Researchers found four genes that could help diagnose severe alopecia areata early.

Melatonin affects cashmere growth in goats by influencing stem cell and certain signaling pathways.

High leptin levels may promote skin cancer and inflammation, suggesting potential for leptin-targeted therapies.

PCOD mainly affects young women, causing symptoms like irregular periods and weight gain, with mixed success from lifestyle changes and medication.

New therapies for rare skin diseases show promise but need more research.